These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9219386)

  • 1. Society for Research on Nicotine and Tobacco.
    Heishman SJ; Balfour DJ; Benowitz NL; Hatsukami DK; Lindstrom JM; Ockene JK
    Addiction; 1997 May; 92(5):615-33. PubMed ID: 9219386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mechanisms and perspectives in nicotine withdrawal.
    Jackson KJ; Muldoon PP; De Biasi M; Damaj MI
    Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural mechanisms underlying nicotine dependence.
    Balfour DJ
    Addiction; 1994 Nov; 89(11):1419-23. PubMed ID: 7841851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
    Kropp RY; Halpern-Felsher BL
    Pediatrics; 2004 Oct; 114(4):e445-51. PubMed ID: 15466070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation intervention: an evidence-based approach.
    Laniado-Laborín R
    Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking Cessation in Chronic Obstructive Pulmonary Disease.
    Tashkin DP
    Semin Respir Crit Care Med; 2015 Aug; 36(4):491-507. PubMed ID: 26238637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
    D'Souza MS
    Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic cigarette use is not associated with quitting of conventional cigarettes in youth smokers.
    Wang MP; Li WH; Wu Y; Lam TH; Chan SS
    Pediatr Res; 2017 Jul; 82(1):14-18. PubMed ID: 28355200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupting nicotine reinforcement: from cigarette to brain.
    Rose JE
    Ann N Y Acad Sci; 2008 Oct; 1141():233-56. PubMed ID: 18991961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hooked from the first cigarette.
    DiFranza JR
    Sci Am; 2008 May; 298(5):82-7. PubMed ID: 18444329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are you in or out? Recruitment of adolescent smokers into a behavioral smoking cessation intervention.
    Thrul J; Stemmler M; Goecke M; Bühler A
    Addict Behav; 2015 Jun; 45():150-5. PubMed ID: 25678303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)].
    Trofor A; Eşanu V; Frasilă EL
    Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications.
    Dube SR; Pesko MF; Xu X
    J Public Health Manag Pract; 2016; 22(1):48-56. PubMed ID: 26594936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological approaches to smoking cessation.
    Mitrouska I; Bouloukaki I; Siafakas NM
    Pulm Pharmacol Ther; 2007; 20(3):220-32. PubMed ID: 16497526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk reduction strategies in smoking].
    Martinet Y; Bohadana A; Wirth N; Spinosa A; Béguinot E
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S109-18; quiz 13S158, 13S159. PubMed ID: 17057636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of nicotine and cigarette smoke on the monoamine transporters.
    Danielson K; Truman P; Kivell BM
    Synapse; 2011 Sep; 65(9):866-79. PubMed ID: 21308797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.